FDA Inspection 636489 — Aesica (frmly: Msd)
The FDA completed an inspection of Aesica (frmly: Msd) on August 6, 2009 in Enfield Middlesex England. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 6, 2009
- Fiscal Year
- 2009
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Enfield Middlesex England (United Kingdom)